One third of 35 to 44-year-olds still rely on the 'Bank of Mum and Dad' according to new research. However, it is the youngest generation of adults who lean on financial help from their parents ...

Mesoblast (ASX:MSB) was the top performer for the year up 835% (as of December 30). On December 18 Mesoblast announced that the US Food and Drug Administration (FDA) had finally approved its therapy ...